IBDEI04X ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6307,1,3,0)
 ;;=3^Irregular Astigmatism
 ;;^UTILITY(U,$J,358.3,6307,1,4,0)
 ;;=4^367.22
 ;;^UTILITY(U,$J,358.3,6307,2)
 ;;=^265373
 ;;^UTILITY(U,$J,358.3,6308,0)
 ;;=V45.69^^36^401^49
 ;;^UTILITY(U,$J,358.3,6308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6308,1,3,0)
 ;;=3^States Following Surg of Eye
 ;;^UTILITY(U,$J,358.3,6308,1,4,0)
 ;;=4^V45.69
 ;;^UTILITY(U,$J,358.3,6308,2)
 ;;=^317957
 ;;^UTILITY(U,$J,358.3,6309,0)
 ;;=V58.71^^36^401^4
 ;;^UTILITY(U,$J,358.3,6309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6309,1,3,0)
 ;;=3^Aftercare Following Surg of Sense Organ
 ;;^UTILITY(U,$J,358.3,6309,1,4,0)
 ;;=4
 ;;^UTILITY(U,$J,358.3,6309,2)
 ;;=^328689
 ;;^UTILITY(U,$J,358.3,6310,0)
 ;;=V45.61^^36^401^9
 ;;^UTILITY(U,$J,358.3,6310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6310,1,3,0)
 ;;=3^Cataract Extraction Status
 ;;^UTILITY(U,$J,358.3,6310,1,4,0)
 ;;=4^V45.61
 ;;^UTILITY(U,$J,358.3,6310,2)
 ;;=^295462
 ;;^UTILITY(U,$J,358.3,6311,0)
 ;;=V72.0^^36^401^21
 ;;^UTILITY(U,$J,358.3,6311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6311,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,6311,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,6311,2)
 ;;=^43432
 ;;^UTILITY(U,$J,358.3,6312,0)
 ;;=V71.89^^36^401^37
 ;;^UTILITY(U,$J,358.3,6312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6312,1,3,0)
 ;;=3^Observe SPEC Condition
 ;;^UTILITY(U,$J,358.3,6312,1,4,0)
 ;;=4^V71.89
 ;;^UTILITY(U,$J,358.3,6312,2)
 ;;=^322082
 ;;^UTILITY(U,$J,358.3,6313,0)
 ;;=V50.1^^36^401^38
 ;;^UTILITY(U,$J,358.3,6313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6313,1,3,0)
 ;;=3^Oth Plastic Surgery
 ;;^UTILITY(U,$J,358.3,6313,1,4,0)
 ;;=4^V50.1
 ;;^UTILITY(U,$J,358.3,6313,2)
 ;;=^87802
 ;;^UTILITY(U,$J,358.3,6314,0)
 ;;=368.8^^36^401^39
 ;;^UTILITY(U,$J,358.3,6314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6314,1,3,0)
 ;;=3^Oth Specific Visual Disturbances
 ;;^UTILITY(U,$J,358.3,6314,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,6314,2)
 ;;=^88172
 ;;^UTILITY(U,$J,358.3,6315,0)
 ;;=368.13^^36^401^40
 ;;^UTILITY(U,$J,358.3,6315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6315,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,6315,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,6315,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,6316,0)
 ;;=998.59^^36^401^41
 ;;^UTILITY(U,$J,358.3,6316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6316,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,6316,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,6316,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,6317,0)
 ;;=368.03^^36^401^5
 ;;^UTILITY(U,$J,358.3,6317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6317,1,3,0)
 ;;=3^Amblyopia,Refractive
 ;;^UTILITY(U,$J,358.3,6317,1,4,0)
 ;;=4^368.03
 ;;^UTILITY(U,$J,358.3,6317,2)
 ;;=^265363
 ;;^UTILITY(U,$J,358.3,6318,0)
 ;;=367.31^^36^401^6
 ;;^UTILITY(U,$J,358.3,6318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6318,1,3,0)
 ;;=3^Anisometropia
 ;;^UTILITY(U,$J,358.3,6318,1,4,0)
 ;;=4^367.31
 ;;^UTILITY(U,$J,358.3,6318,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,6319,0)
 ;;=367.20^^36^401^7
 ;;^UTILITY(U,$J,358.3,6319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6319,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,6319,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,6319,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,6320,0)
 ;;=367.0^^36^401^31
 ;;^UTILITY(U,$J,358.3,6320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6320,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,6320,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,6320,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,6321,0)
 ;;=367.1^^36^401^36
 ;;^UTILITY(U,$J,358.3,6321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6321,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,6321,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,6321,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,6322,0)
 ;;=V43.1^^36^401^44
 ;;^UTILITY(U,$J,358.3,6322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6322,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,6322,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,6322,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,6323,0)
 ;;=367.9^^36^401^46
 ;;^UTILITY(U,$J,358.3,6323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6323,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,6323,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,6323,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,6324,0)
 ;;=365.04^^36^401^26
 ;;^UTILITY(U,$J,358.3,6324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6324,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,6324,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,6324,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,6325,0)
 ;;=365.01^^36^401^30
 ;;^UTILITY(U,$J,358.3,6325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6325,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,6325,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,6325,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,6326,0)
 ;;=365.71^^36^401^24
 ;;^UTILITY(U,$J,358.3,6326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6326,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,6326,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,6326,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,6327,0)
 ;;=365.72^^36^401^25
 ;;^UTILITY(U,$J,358.3,6327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6327,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,6327,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,6327,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,6328,0)
 ;;=365.73^^36^401^28
 ;;^UTILITY(U,$J,358.3,6328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6328,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,6328,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,6328,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,6329,0)
 ;;=362.51^^36^401^1
 ;;^UTILITY(U,$J,358.3,6329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6329,1,3,0)
 ;;=3^AMD,Dry
 ;;^UTILITY(U,$J,358.3,6329,1,4,0)
 ;;=4^362.51
 ;;^UTILITY(U,$J,358.3,6329,2)
 ;;=^268636
 ;;^UTILITY(U,$J,358.3,6330,0)
 ;;=362.52^^36^401^2
 ;;^UTILITY(U,$J,358.3,6330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6330,1,3,0)
 ;;=3^AMD,Wet/Exudative
 ;;^UTILITY(U,$J,358.3,6330,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,6330,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,6331,0)
 ;;=362.04^^36^401^14
 ;;^UTILITY(U,$J,358.3,6331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6331,1,3,0)
 ;;=3^DM Mild NPDR
 ;;^UTILITY(U,$J,358.3,6331,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,6331,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,6332,0)
 ;;=362.05^^36^401^15
 ;;^UTILITY(U,$J,358.3,6332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6332,1,3,0)
 ;;=3^DM Moderate NPDR
 ;;^UTILITY(U,$J,358.3,6332,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,6332,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,6333,0)
 ;;=362.06^^36^401^17
 ;;^UTILITY(U,$J,358.3,6333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6333,1,3,0)
 ;;=3^DM Severe NPDR
 ;;^UTILITY(U,$J,358.3,6333,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,6333,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,6334,0)
 ;;=362.02^^36^401^16
 ;;^UTILITY(U,$J,358.3,6334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6334,1,3,0)
 ;;=3^DM PDR
 ;;^UTILITY(U,$J,358.3,6334,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,6334,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,6335,0)
 ;;=379.39^^36^401^45
 ;;^UTILITY(U,$J,358.3,6335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6335,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,6335,1,4,0)
 ;;=4^379.39
 ;;^UTILITY(U,$J,358.3,6335,2)
 ;;=^87515
 ;;^UTILITY(U,$J,358.3,6336,0)
 ;;=367.9^^36^401^18
 ;;^UTILITY(U,$J,358.3,6336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6336,1,3,0)
 ;;=3^Disorder of Refraction
 ;;^UTILITY(U,$J,358.3,6336,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,6336,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,6337,0)
 ;;=373.2^^36^401^35
 ;;^UTILITY(U,$J,358.3,6337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6337,1,3,0)
 ;;=3^Meibomianitis
 ;;^UTILITY(U,$J,358.3,6337,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,6337,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,6338,0)
 ;;=V58.69^^36^401^33
 ;;^UTILITY(U,$J,358.3,6338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6338,1,3,0)
 ;;=3^Long Term Use of Medication
 ;;^UTILITY(U,$J,358.3,6338,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,6338,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,6339,0)
 ;;=379.24^^36^401^51
 ;;^UTILITY(U,$J,358.3,6339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6339,1,3,0)
 ;;=3^Vitreous Floaters
 ;;^UTILITY(U,$J,358.3,6339,1,4,0)
 ;;=4^379.24
 ;;^UTILITY(U,$J,358.3,6339,2)
 ;;=^88242
 ;;^UTILITY(U,$J,358.3,6340,0)
 ;;=V80.2^^36^401^47
 ;;^UTILITY(U,$J,358.3,6340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6340,1,3,0)
 ;;=3^Screening for Eye Condition
 ;;^UTILITY(U,$J,358.3,6340,1,4,0)
 ;;=4^V80.2
 ;;^UTILITY(U,$J,358.3,6340,2)
 ;;=^295685
 ;;^UTILITY(U,$J,358.3,6341,0)
 ;;=V70.5^^36^401^48
 ;;^UTILITY(U,$J,358.3,6341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6341,1,3,0)
 ;;=3^Screening,Occupational
 ;;^UTILITY(U,$J,358.3,6341,1,4,0)
 ;;=4^V70.5
 ;;^UTILITY(U,$J,358.3,6341,2)
 ;;=^295595
 ;;^UTILITY(U,$J,358.3,6342,0)
 ;;=365.11^^36^401^27
 ;;^UTILITY(U,$J,358.3,6342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6342,1,3,0)
 ;;=3^Glaucoma Primary Open Angle
 ;;^UTILITY(U,$J,358.3,6342,1,4,0)
 ;;=4^365.11
 ;;^UTILITY(U,$J,358.3,6342,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,6343,0)
 ;;=365.70^^36^401^29
 ;;^UTILITY(U,$J,358.3,6343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6343,1,3,0)
 ;;=3^Glaucoma Stage NOS
 ;;^UTILITY(U,$J,358.3,6343,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,6343,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,6344,0)
 ;;=365.74^^36^401^23
 ;;^UTILITY(U,$J,358.3,6344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6344,1,3,0)
 ;;=3^Glaucoma Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,6344,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,6344,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,6345,0)
 ;;=373.32^^37^402^48
 ;;^UTILITY(U,$J,358.3,6345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6345,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,6345,1,4,0)
 ;;=4^373.32
